BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) ...

After showing its wrist-worn bioelectronic device could help people reduce hand tremors, Cala Health has raised $77 million to help expand its technology to new uses in Parkinson’s disease and other ...

After getting de novo clearance for its device from the Food and Drug Administration in 2018, Cala Health touted data from a post-market analysis that it hopes will prove the device’s benefit to ...

SANTA CLARA, Calif., Jan. 9, 2020 /PRNewswire/ -- Based on its recent analysis of the North American essential tremor (ET) treatment market, Frost & Sullivan recognizes Cala Health, Inc. with the 2019 ...

Ben Duncan’s doctor asked him to draw a spiral on a sheet of notebook paper. Tremors sent his hand shaking and scribbling all over the page as he tried to draw. What was left on the paper told the ...

In August, Cala Health Inc. reported results from its pivotal PROSPECT study showing significant improvement in hand tremors with use of its Cala Trio wearable neuromodulation therapy. Now the company ...

Cala Health recently published a post-market surveillance study that demonstrates the long-term efficacy of its wrist-based wearable for people with essential tremor, finding that the device reduced ...

SAN ANTONIO — Most don't think about their hand functions until they don't have them. Now, a fairly new device approved by the FDA has given those with tremors renewed hope their lives can nearly ...

Please provide your email address to receive an email when new articles are posted on . A Bay Area bioelectronic medicine company announced the commercial launch of its next-generation Cala kIQ System ...

Cala Trio™ allows patients to gain relief from hand tremors in the comfort of their homes SANTA CLARA, California, Jan. 9, 2020 /PRNewswire/ -- Based on its recent analysis of the North American ...